Guggenheim Capital LLC Astrazeneca PLC Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Guggenheim Capital LLC holds 207,350 shares of AZN stock, worth $13.7 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

207,350

Previous 219,379 5.48%

Holding current value

$13.7 Million

Previous $17.1 Million 5.57%

% of portfolio

0.12%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$76.67 - $87.62 $922,263 - $1.05 Million	-12,029 Reduced 5.48%	207,350 $16.2 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $133,954 - $162,064	2,005 Added 0.92%	219,379 $17.1 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $332,003 - $378,460	-5,440 Reduced 2.44%	217,374 $14.7 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $374,929 - $419,698	6,058 Added 2.79%	222,814 $15 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $1.3 Million - $1.44 Million	20,086 Added 10.21%	216,756 $14.7 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $469,305 - $508,912	-6,713 Reduced 3.3%	196,670 $14.1 Million
Q1 2023 May 10, 2023	BUY	$63.15 - $71.6 $367,911 - $417,141	5,826 Added 2.95%	203,383 $14.1 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $1.75 Million - $2.28 Million	-32,337 Reduced 14.07%	197,557 $13.4 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $431,370 - $1.1 Million	-8,136 Reduced 3.42%	229,894 $12.6 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $1.77 Million - $2.12 Million	-29,822 Reduced 11.13%	238,030 $15.7 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $599,268 - $721,875	-10,755 Reduced 3.86%	267,852 $17.8 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $3.63 Million - $4.29 Million	-67,164 Reduced 19.42%	278,607 $16.2 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $16.6 Million - $18.2 Million	298,595 Added 632.94%	345,771 $20.8 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $83,572 - $103,870	1,726 Added 3.8%	47,176 $2.83 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $370,064 - $427,190	7,847 Added 20.87%	45,450 $2.26 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $800,191 - $956,865	16,492 Added 78.12%	37,603 $1.88 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $303,878 - $349,858	-5,726 Reduced 21.34%	21,111 $1.16 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $224,594 - $288,220	5,211 Added 24.1%	26,837 $1.42 Million
Q1 2020 Jun 02, 2020	SELL	$37.79 - $51.33 $153,502 - $208,502	-4,062 Reduced 15.81%	21,626 $965,000
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $15,710 - $18,670	370 Added 1.46%	25,688 $1.28 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $518,230 - $587,335	-12,917 Reduced 33.78%	25,318 $1.13 Million
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $466,335 - $521,375	-12,509 Reduced 24.65%	38,235 $1.58 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $279,270 - $338,524	7,869 Added 18.35%	50,744 $2.05 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $622,049 - $700,185	-16,876 Reduced 28.24%	42,875 $1.63 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $21,203 - $24,229	610 Added 1.03%	59,751 $2.36 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $15,616 - $16,746	452 Added 0.77%	59,141 $2.08 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $3 Million - $3.33 Million	-91,031 Reduced 60.8%	58,689 $2.05 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $820,765 - $889,568	-25,577 Reduced 14.59%	149,720 $5.2 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $5.08 Million - $5.96 Million	175,297	175,297 $5.94 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Astrazeneca PLC Transaction History